REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,075,678 | +7.4% | 10,550 | +5.0% | 0.07% | +169.2% |
| Q1 2021 | $1,002,000 | +34.5% | 10,050 | +31.3% | 0.03% | -27.8% |
| Q3 2020 | $745,000 | +1141.7% | 7,652 | +1887.5% | 0.04% | +1100.0% |
| Q2 2020 | $60,000 | -98.5% | 385 | -98.0% | 0.00% | -98.0% |
| Q4 2019 | $3,971,000 | -8.2% | 19,423 | -63.9% | 0.15% | -22.6% |
| Q3 2019 | $4,326,000 | +7.4% | 53,876 | +26.2% | 0.20% | -1.5% |
| Q2 2019 | $4,028,000 | +1479.6% | 42,694 | +244.0% | 0.20% | +942.1% |
| Q1 2018 | $255,000 | – | 12,412 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
| Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
| First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
| Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
| MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
| Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
| Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
| Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
| KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
| Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |